Enlivex Therapeutics
ENLV
ENLV
19 hedge funds and large institutions have $4.31M invested in Enlivex Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
2
Closed
1
Calls
$71K
Puts
$25K
Net Calls
+$46K
Net Calls Change
+$14K
Top Buyers
1 |
AC
1
Armistice Capital
New York
|
$3.59M |
2 |
SIC
2
Sigma Investment Counselors
Northville,
Michigan
|
$50.4K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$5.41K |
4 |
4
Renaissance Technologies
New York
|
$126K |
5 |
S
5
SignatureFD
Atlanta,
Georgia
|
$5.04K |
Top Sellers
1 |
XT
1
XTX Topco
George Town,
Cayman Islands
|
$38.1K |
2 |
![]()
2
Group One Trading
Chicago,
Illinois
|
$9.63K |
3 |
3
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$0 |